Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition

Charles Bayard, Guillaume Canaud, Célia Chapelle et al.|The Journal of Experimental Medicine|2023

Cited by 12